Demonstration of a cellular immune response in Halothane-exposed guinea pigs

Toxicology and Applied Pharmacology

Volumn 143, Issue 2, 1997, Pages 245-255

  Furst, Sylvia M ^a   Luedke, Dennis ^a   Gaw, Htoo Htoo ^a   Reich, Richard ^a   Gandolfi, A Jay ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HALOTHANE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; GUINEA PIG; IMMUNE RESPONSE; INHALATIONAL DRUG ADMINISTRATION; KUPFFER CELL; LIVER TOXICITY; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE TRANSFORMATION TEST; MALE; NONHUMAN; SPLEEN CELL;

EID: 0030972414     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1996.8093     Document Type: Article

References (52)

1. Bell S. J. D., Pichler W. J. Penicillin-allergic patients react to penicillin-modified ;ldquo;self" Allergy. 44:1989;199-203.
2. Berg P. A., Becker E. W. The lymphocyte transformation test - A debated method for the evaluation of drug allergic hepatic injury. J. Hepatol. 22:1995;115-118.
3. Boelsterli U. A., Zimmerman H. J., Kretz-Rommel A. Idiosyncratic liver toxicity of nonsteroidal antiinflammatory drugs: Molecular mechanisms and pathology. Crit. Rev. Toxicol. 25:1995;207-235.
4. Bottinger L., Dalen E., Hallen B. Halothane-induced liver damage: An analysis of material reported to the Swedish Adverse Drug Reaction Committee 1966-1973. Anaesthesiol. Scand. 20:1976;40-46.
5. Callis A. H., Brooks S. D., Roth T. P., Gandolfi A. J., Brown B. R. Characterization of a halothane-induced humoral immune response in rabbits. Clin. Exp. Immunol. 67:1987;343-351.
6. Chen M. L., Gandolfi A. J. Humoral immune response and hepatotoxicity after multiple-halothane exposures in guinea pigs. Toxicologist. 15:1995;102.
7. Chen M. L., Gandolfi A. J. Effect of pre-existing anti-TFA antibodies on the humoral immune response and hepatotoxicity after subsequent halothane expsoure. Toxicologist. 30:1996;293.
8. Christen U., Burgin M., Gut J. Halothane metabolism: Kupffer cells carry and partially process trifluoroacetylated protein adducts. Biochem. Biophys. Res. Commun. 175:1991;256-262.
9. Clarke J. B., Thomas C., Chen M., Hastings K. L., Gandolfi A. J. Halogenated anesthetics form liver adducts and antigens that cross-react with halothane-induced antibodies. Int. Arch. Allergy Immunol. 108:1995;24-32.
10. De Gruijl T. D., Moore J. J., De Vries, Von Blomerg-Van Der Flier B. M. E., Fonk J. C. E., Scheper R. J. Augmentation of antigen-specific lymphoproliferative responsesin vitro. Clin. Exp. Immunol. 96:1994;535-540.
11. Dieli F., Asherson G. L., Bonanno C. T., Sireci G., Salerno A. Major histocompatibility complex control of the class of the immune response to the hapten trinitrophenyl. Immunology. 84:1995;355-359.
12. Furst S. M., Gandolfi A. J. Cellular immune mediation of halothane-induced hepatotoxicity. Toxicologist. 30:1996;63.
13. Garner C. M., Richards G. M., Adu D., Pall A. A., Taylor C. M., Richards N. T., Michael J. Intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) expression and function on cultured human glomerular epithelial cells. Clin. Exp. Immunol. 95:1994;322-326.
14. Gregory S. H., Wing E. J. Accessory function of Kupffer cells in the antigen-specific blastogenic response of an L3T4+ T-lymphocyte clone to Listeria monocytogenes. Infect. Immunol. 58:1990;2313-2319.
15. Gruenke L. D., Konopka D. R., Koop D. R., Waskell L. A. Characterization of halothane oxidation by hepatic microsomes and purified cytochrome P-450 using a gas chromatographic mass spectrometric assay. J. Pharmacol. Exp. Ther. 246:1988;454-459.
16. Harris J. W., Pohl L. R., Martin J. L., Anders M. W. Tissue acylation by the chlorofluorocarbon substitute 2,2-chloro-1,1,1-trifluoroethane. Proc. Natl. Acad. Aci. USA. 88:1991;1407-1410.
17. Hertl M., Geisel J., Boecker C., Merk H. F. Selective generation of CD8+ T cell clones from the peripheral blood of patients with cutaneous reactions to beta-lactam antibiotics. Br. J. Dermatol. 128:1993;619.
18. Hubbard A. K., Roth T. P., Gandolfi A. J. Elicitation of a cell mediated immune response to a reactive intermediate of halothane. Toxicologist. 8:1988;12.
19. Hubbard A. K., Roth T. P., Gandolfi A. J. Immunological methods for investigating the mechanisms of halothane hepatotoxicity. Hepatotoxicology. 1991;CRC Press, Boca Raton. p. 627-665.
20. Inoue S., Yamashita A. The phenotypic and functional changes of rat Kupffer cells cultured with interleukin-2. Toxicol. Pathol. 21:1993;71-80.
21. Kashima R., Okada J., Ikeda Y. Lymph node cell proliferation assay in guinea pigs for the assessment of sensitizing potentials of chemical compounds. Food Chem. Toxicol. 32:1994;831-836.
22. Kenna J. G., Neuberger J., Williams R. Identification by immunoblotting of three halothane-induced liver microsomal polypeptide antigens recognized by antibodies in sera from patients with halothane-associated hepatitis. J. Pharmacol. Exp. Ther. 242:1987;733-740.
23. Kenna J. G., Satoh H., Christ H., Pohl L. Metabolic basis for a drug hypersensitivity: Antibodies in sera from patients with halothane hepatitis recognize liver neoantigens that contain the trifluoroacetyl group derived from halothane. J. Pharmacol. Exp. Ther. 245:1988;1103-1109.
24. Knook D., Sleyster E. Separation of Kupffer and endothelial cells of rat liver by centrifugal elutriation. Exp. Cell Res. 99:1976;444-449.
25. Kretz-Rommel A., Boelsterli U. A. Cytotoxic activity of T cells and non-T cells from diclofenac-immunized mice against cultured syngeneic hepatocytes exposed to diclofenac. Hepatology. 22:1995;213-222.
26. Lind R. C., Gandolfi A. J. The role of oxidative biotransformation of halothane in the guinea pig model of halothane-associated hepatotoxicity. Anesthesiology. 70:1989;649-653.
27. Lind R. C., Gandolfi A. J., Hall P. M. Age and gender influence halothane-associated hepatotoxicity in strain 13 guinea pigs. Anesthesiology. 71:1989;878-884.
28. Lind R. C., Gandolfi A. J., Hall P. M. Covalent binding of oxidative biotransformation intermediates is associated with halothane hepatotoxicity in guinea pgis. Anesthesiology. 73:1990;1208-1213.
29. Lind R. C., Gandolfi A. J., Hall P. M. Subanesthetic halothane is hepatotoxic in the guinea pig. Anesthesiol. Analg. 74:1992;559-563.
30. Maria V. A. J., Pinto L., Victorino R. M. M. Lymphocyte reactivity to ex-vivo drug antigens in drug-induced hepatitis. J. Hepatol. 21:1994;151-158.
31. Martin S., Weltzien H. T cell recognition of haptens, a molecular view. Int. Arch. Allergy Appl. Immunol. 104:1994;10.
32. Mathieu A., DiPadua D., Kahan B. D., Galdabini J. J., Mills J. Correlation between specific immunity to a metabolite of halothane and hepatic lesions after multiple exposures. Anesthesiol. Analg. 54:1975;332-339.
33. Mauri-Hellweg D., Bettens F., Mauri D., Brander C., Hunziker T., Pichler W. J. Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine. J. Immunol. 155:1995;462-472.
34. Ogle C. K., Wu J. Z., Mao X., Szczur K., Alexander J. W., Ogle J. D. Heterogeneity of Kupffer cells and splenic, alveolar, and peritoneal macrophages for the production of TNF, IL-1, and IL-6. Inflammation. 18:1994;511-523.
35. Paronetto F., Popper H. Lymphocyte stimulation induced by halothane in patients with hepatitis following exposure to halothane. N. Engl. J. Med. 282:1970;277-280.
36. Pessayre D. Role of reactive metabolites in drug-induced hepatitis. J. Hepatol. 23:1995;16-24.
37. Pohl L. R., Kenna J. G., Satoh H., Christ D. D., Martin J. L. Neo-antigens associated with halothane hepatitis. Drug Metab. Rev. 20:1989;203-217.
38. Rogoff T. M., Lipsky P. E. Characterization of isolated guinea pig Kupffer cells accessory cell function in mitogen-inducted T lymphocyte activation. J. Immunol. 123:1979;1920-1927.
39. Rogoff T. M., Lipsky P. E. Antigen presentation by isolated guinea pig Kupffer cells. J. Immunol. 124:1980;1740-1744.
40. Roland C. R., Mangino M. J., Flye M. W. Lanthanide "blockade" of antigen-presenting cells suppresses lymphocyte proliferation by inducing nitric oxide synthesis. J. Surg. Res. 54:1993;401-410.
41. Squiers E. C., Brunson M. E., Salomon D. R. Kupffer cells can present alloantigenin vitro. J. Surg. Res. 55:1993;571-574.
42. Stejskal V. D. M., Forsbeck M., Cederbrant K. E., Asteman O. Mercury-specific lymphocytes: An indication of mercury allergy in man. J. Clin. Immunol. 16:1996;31-40.
43. Stroben W. Wright-Giemsa and nonspecific esterase staining of cells. Coligan J. E., Kruisbeek A. M., Margulies D. H., Shevach E. M., Strober W. Current Protocols in Immunology. 1994;A3.5 Greene/Wiley, New York.
44. Tsutsui H., Terano Y., Sakagami C., Hasegawa I., Mizoguchi Y., Morisawa S. Drug-specific T cells derived from patients with drug-induced allergic hepatitis. J. Immunol. 149:1992;706-716.
45. Vergani D., Tsantoulas D., Eddleston A. L.W.F., Davis M., Williams R. Sensitization to halothane-altered liver components in severe hepatic necrosis after halothane anesthesia. Lancet. 2:1978;801-803.
46. Vergani D., Mieli-Vergani G., Alberti A., Neuberger J., Eddleston A. L. W. R., Davis M., Williams R. Antibodies to the surface of halothane altered rabbit hepatocytes in patients with halothane-associated hepatitis. N. Engl. J. Med. 303:1980;66-71.
47. Victorino R. M. M., Maria V. A. J., Pinto L. A. Evidence for prostaglandin-producing suppressor cells in drug-induced liver injury and implications in the diagnosis of drug sensitization. Clin. Exp. Immunol. 87:1992;132-137.
48. Xu Q., Wang R., Jiang J., Wu F., Jinfu Lu., Kiang Tan P., Xu L. Liver injury model in mice induced by a cellular immunologic mechanism-delayed-type hypersensitivity-induced liver injury to picryl chloride and phenotype of effector cell. Cell. Immunol. 167:1996;38-43.
49. Yokoyama H., Ishii H., Nagata S. Experimental hepatitis induced by ethanol after immunization with acetaldehyde adducts. Hepatology. 17:1993;14-19.
50. Yoshimura T., Kurita C., Yamazaki F., Nakano S., Nagai H. Lymphocyte stimulation test with tetrazolium-based colorimetric assay for diagnosis of drug-induced allergic hepatitis. Biol. Pharm. Bull. 17:1994;921-926.
51. Young J. L., Daser A., Beverley P. C. L. In vitro. J. Immunol. Methods. 182:1995;177-184.
52. Zoller J., Partridge T., Olsen I. Interactions between cardiomyocytes and lymphocytes in tissue culture: An in vitro model of inflammatory heart disease. J. Mol. Cell. Cardiol. 26:1994;627-638.